BAMCO Inc’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

BAMCO Inc’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-400,000	Closed	-$14.2M	–	373
2018 Q1	$14.2M	Buy	+400,000	New	+$15.7M	0.07%	188
2017 Q4	–	Sell	-500,000	Closed	-$26.1M	–	329
2017 Q3	$26.1M	Hold	500,000	–	–	0.12%	157
2017 Q2	$29.3M	Sell	500,000 -250,000	-33%	-$13M	0.15%	139
2017 Q1	$34.4M	Sell	750,000 -550,000	-42%	-$27.4M	0.18%	123
2016 Q4	$68.4M	Hold	1,300,000	–	–	0.39%	63
2016 Q3	$58M	Sell	1,300,000 -7,428	-0.6%	-$322K	0.31%	82
2016 Q2	$49.9M	Sell	1,307,428 -125,000	-9%	-$5.49M	0.27%	90
2016 Q1	$59M	Sell	1,432,428 -2,200	-0.2%	-$90.7K	0.31%	79
2015 Q4	$69.6M	Buy	1,434,628 +57,600	+4%	+$2.56M	0.32%	81
2015 Q3	$55.1M	Sell	1,377,028 -28,000	-2%	-$1.22M	0.25%	101
2015 Q2	$56.4M	Buy	1,405,028 +674,628	+92%	+$23.3M	0.22%	113
2015 Q1	$23.9M	Sell	730,400 -3,600	-0.5%	-$99.4K	0.09%	196
2014 Q4	$18.9M	Buy	+734,000	New	+$17.5M	0.08%	213

Other funds holding SYNH

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc's SYNH Position: Q2 2018 in Review

BAMCO Inc sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2018, closing a stake of 400,000 shares — an estimated $14.2M sold.

BAMCO Inc first reported a position in SYNH in Q4 2014 and held it in 13 quarters. The position peaked at $69.6M in Q4 2015. 213 funds tracked by Wall St. Rank hold SYNH as of Q2 2018.

BAMCO Inc reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2018 after selling out during the quarter.
BAMCO Inc sold 400,000 Syneos Health, Inc. Class A Common Stock shares in Q2 2018, an estimated $14.2M.
BAMCO Inc first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 13 quarters.
BAMCO Inc's Syneos Health, Inc. Class A Common Stock position peaked at $69.6M in Q4 2015.
213 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2018.

Based on BAMCO Inc's 13F filing for Q2 2018, filed 14 Aug 2018.